Companies and consumers are talking in a different way these days about cannabidiol (CBD), a chemical compound derived from the cannabis plant. But even as the conversation changes, one thing remains the same. Before making claims about purported health effects of CBD products, advertisers need sound science to support their statements. That’s the message of warning letters FTC staff just sent to three businesses that sell oils, creams, capsules, and gummies that contain CBD.